Comparative clinical response, safety, and institutional drug use efficiency of intravenous azithromycin versus erythromycin in pediatric <i>Mycoplasma pneumoniae</i> pneumonia: a real-world evidence study.

Front Cell Infect Microbiol · 2026 · PMC12945838 · PMID 41769341

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The treatment × age interaction suggested stronger separation in ≥8 years, but did not reach statistical significance ( P _interaction = 0.096) ( Supplementary Table S6 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Comparative clinical response, safety, and institutional drug use efficiency of intravenous azithromycin versus erythromycin in pediatric &lt;i&gt;Mycoplasma pneumoniae&lt;/i&gt; pneumonia: a real-world evidence study.

The sentences

Comparative clinical response, safety, and institutional drug use efficiency of intravenous azithromycin versus erythromycin in pediatric <i>Mycoplasma pneumoniae</i> pneumonia: a real-world evidence study.